{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:15:22Z","timestamp":1760188522904},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[1984,9,1]],"date-time":"1984-09-01T00:00:00Z","timestamp":462844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1984,9]]},"DOI":"10.1007\/bf01712002","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T06:10:35Z","timestamp":1118556635000},"page":"855-858","source":"Crossref","is-referenced-by-count":8,"title":["Captopril in Cushing's syndrome"],"prefix":"10.1007","volume":"62","author":[{"given":"P.","family":"Greminger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Groth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Tenschert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Siegenthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01712002_CR1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0028-1093727","volume":"7","author":"R Beckerhoff","year":"1975","unstructured":"Beckerhoff R, Nussberger J, Vetter W, Siegenthaler W (1975) Problems connected with plasma renin activity measurements by angiotensin I radioimmunoassay. Horm Met Res 7:342\u2013347","journal-title":"Horm Met Res"},{"key":"BF01712002_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-90-1-19","volume":"90","author":"HR Brunner","year":"1979","unstructured":"Brunner HR, Gavras H, Waeber B, Kershaw GR, Turini GA, Vukovich RA, McKinstry D, Gavras I (1979) Oral angiotensin converting enzyme inhibitor in long term treatment of hypertensive patients. Ann Intern Med 90:19\u201323","journal-title":"Ann Intern Med"},{"key":"BF01712002_CR3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-90-5-829","volume":"90","author":"EM Gold","year":"1979","unstructured":"Gold EM (1979) The Cushing syndromes: changing views of diagnosis and treatment. Ann Intern Med 90:829\u2013844","journal-title":"Ann Intern Med"},{"key":"BF01712002_CR4","first-page":"103","volume-title":"Endocrinology in Hypertension","author":"P Greminger","year":"1982","unstructured":"Greminger P, Tenschert W, Vetter W, L\u00fcscher T, Vetter H (1982) Hypertension in Cushing's syndrome. In: Mantero F, Biglieri EG, Edwards CRW (eds) Endocrinology in Hypertension. Academic Press, London New York, pp 103\u2013110"},{"key":"BF01712002_CR5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/0002-9149(82)90362-9","volume":"49","author":"J Havelka","year":"1982","unstructured":"Havelka J, Vetter H, Studer A, Greminger P, L\u00fcscher T, Wollnik S, Siegenthaler W, Vetter W (1982) Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension. Am J Cardiol 49:1467\u20131474","journal-title":"Am J Cardiol"},{"key":"BF01712002_CR6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1210\/jcem-37-1-110","volume":"37","author":"LR Krakoff","year":"1973","unstructured":"Krakoff LR (1973) Measurement of plasma renin substrate by radioimmunoassay of angiotensin I: Concentration in syndromes associated with steroid excess. J Clin Endocrinol Metab 37:110\u2013117","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712002_CR7","first-page":"479","volume-title":"Clinics in Endocrinology and Metabolism","author":"LR Krakoff","year":"1981","unstructured":"Krakoff LR, Elijovich F (1981) Cushing's syndrome and exogenous glucocorticoid hypertension. In: Clinics in Endocrinology and Metabolism. Saunders, London, pp 479\u2013488"},{"key":"BF01712002_CR8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0002-9343(75)90572-0","volume":"58","author":"LR Krakoff","year":"1975","unstructured":"Krakoff LR, Nicolis G, Amsel B (1975) Pathogenesis of hypertension in Cushing's syndrome. Am J Med 58:216\u2013220","journal-title":"Am J Med"},{"key":"BF01712002_CR9","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-57-5-892","volume":"57","author":"DF Lyons","year":"1983","unstructured":"Lyons DF, Kem DC, Brown RD, Hanson CS, Carollo ML (1983) Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 57:892\u2013896","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712002_CR10","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.2.6198.1106","volume":"2","author":"GA MacGregor","year":"1979","unstructured":"MacGregor GA, Markandu ND, Roulsten JE, Jones JC (1979) Essential hypertension: effect of an oral inhibitor of angiotensin converting enzyme. Br Med J 2:1106\u20131109","journal-title":"Br Med J"},{"key":"BF01712002_CR11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(71)90264-6","volume":"51","author":"M Schambelan","year":"1971","unstructured":"Schambelan M, Slaton PE, Biglieri EG (1971) Mineralocorticoid production in hyperadrenocorticism. Am J Med 51:299\u2013303","journal-title":"Am J Med"},{"key":"BF01712002_CR12","first-page":"70","volume":"111","author":"W Tenschert","year":"1981","unstructured":"Tenschert W, Vetter H, Siebenschein R, Holland-Cunz B, Siegenthaler W, Vetter W (1981) Spezielle Diagnostik des Cushing-Syndromes. Schweiz Med Wochenschr 111:70\u201373","journal-title":"Schweiz Med Wochenschr"},{"key":"BF01712002_CR13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01469145","volume":"54","author":"W Vetter","year":"1976","unstructured":"Vetter W, Vetter H, Beckerhoff R, Redlich B, Cottier P, Siegenthaler W (1976) The effect of saralasin (1-Sar-Ala-Angiotensin II) on blood pressure in patients with Cushing's syndrome. Klin Wochenschr 54:661\u2013663","journal-title":"Klin Wochenschr"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01712002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01712002\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01712002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T12:47:45Z","timestamp":1557319665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01712002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,9]]},"references-count":13,"journal-issue":{"issue":"18","published-print":{"date-parts":[[1984,9]]}},"alternative-id":["BF01712002"],"URL":"https:\/\/doi.org\/10.1007\/bf01712002","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,9]]}}}